Esther Rajavelu

Chief Executive Officer at SPERO THERAPEUTICS, INC.

Net worth: 2 M $ as of 2026-06-29

47 year

84 connections

Finance

Consumer Services

Health Technology

Profile

Esther Rajavelu is currently President, CEO, CFO, Treasurer & Director at Spero Therapeutics, Inc. since 2025.
Former positions include Chief Financial Officer & Treasurer at Fulcrum Therapeutics, Inc. from 2022 to 2023; Senior Equities Research Analyst at UBS Securities LLC from 2020 to 2022; Executive Director & Senior Analyst at Oppenheimer & Co., Inc. (Broker) from 2018 to 2020; Research Analyst at Deutsche Bank Securities, Inc. from 2014 to 2018; Vice President-Life Sciences at Ernst & Young Capital Advisors LLC from 2011 to 2014; Vice President at Merrill Lynch, Pierce, Fenner & Smith, Inc.; Analyst at J.P.
Morgan & Co., Inc. (Old); Associate at Towers Perrin Capital Markets, Inc. Education includes undergraduate degree from Wesleyan University and MBA from The Wharton School of the University of Pennsylvania.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
SPERO THERAPEUTICS, INC. 1.7%	2026-05-03	986,851 ( 1.7% )	2 M $	2026-06-29

Esther Rajavelu active positions

Companies	Position	Start
SPERO THERAPEUTICS, INC.	Chief Executive Officer	2025-01-09

All active positions of Esther Rajavelu

Former positions of Esther Rajavelu

Companies	Position	End
FULCRUM THERAPEUTICS, INC.	Director of Finance/CFO	2023-04-20
UBS Securities LLC UBS Securities LLC Investment Banks/BrokersFinance Provides brokerage services	Analyst-Equity	2021-12-31
Oppenheimer & Co., Inc. (Broker) Oppenheimer & Co., Inc. (Broker) Investment Banks/BrokersFinance Provides brokerage services	Analyst-Equity	2019-12-31
Deutsche Bank Securities, Inc. Deutsche Bank Securities, Inc. Investment Banks/BrokersFinance Provides brokerage services	Analyst-Equity	2018-05-31
Ernst & Young Capital Advisors LLC Ernst & Young Capital Advisors LLC Investment Banks/BrokersFinance Provides brokerage services	Corporate Officer/Principal	2013-12-31

See the detail of Esther Rajavelu's experience

Training of Esther Rajavelu

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Esther Rajavelu's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	11
Deutsche Bank Securities, Inc. Deutsche Bank Securities, Inc. Investment Banks/BrokersFinance Provides brokerage services	Finance
UBS Securities LLC UBS Securities LLC Investment Banks/BrokersFinance Provides brokerage services	Finance
Towers Perrin Capital Markets, Inc.
J.P. Morgan & Co., Inc. (Old) J.P. Morgan & Co., Inc. (Old) Regional BanksFinance Provides commercial banking and investment advisory services	Finance
Oppenheimer & Co., Inc. (Broker) Oppenheimer & Co., Inc. (Broker) Investment Banks/BrokersFinance Provides brokerage services	Finance
Wesleyan University Wesleyan University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Merrill Lynch, Pierce, Fenner & Smith, Inc. Merrill Lynch, Pierce, Fenner & Smith, Inc. Investment Banks/BrokersFinance Provides brokerage services	Finance
Ernst & Young Capital Advisors LLC Ernst & Young Capital Advisors LLC Investment Banks/BrokersFinance Provides brokerage services	Finance
Spero Therapeutics, Inc. Spero Therapeutics, Inc. BiotechnologyHealth Technology Develops therapies for the treatment of bacterial infections	Health Technology
The Wharton School of the University of Pennsylvania The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Fulcrum Therapeutics, Inc. Fulcrum Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops medicines for patients by transforming gene regulation in disease	Health Technology